Optimising bifurcation PCI: learning from randomised controlled trials

Session comprising selected EuroPCR 2026 abstract submissions

Moderators: M. Ntsekhe, C. Trani

Summary

This session delves into optimizing bifurcation PCI by examining contemporary European practices and outcomes from multiple randomized controlled trials. Key topics include multivessel TALENT trial results, 30-day outcomes of left main PCI with sirolimus-eluting stents from the NAGOMI COMPLEX study, comparative insights from the CROSS-LCX Registry on ostial left circumflex lesions, the impact of proximal optimization technique (POT) on long-term outcomes in LM bifurcation PCI, and a comprehensive review of optimal dual antiplatelet therapy duration in bifurcation PCI.

Presentations available when logged in:

  • Left main PCI with a sirolimus-eluting stent: 30-day outcomes from the NAGOMI COMPLEX study
  • Crossover vs. ostial single stent implantation for ostial left circumflex lesions: multicentre CROSS-LCX Registry
  • Impact of POT on three-year outcomes in LM bifurcation PCI: post-hoc analysis of the EBC-MAIN Trial
  • Optimal DAPT duration in bifurcation PCI: a systematic review and meta-analysis